Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
p38 MAP kinase inhibitor |
| gptkbp:alternativeName |
gptkb:RWJ_64809
p38 inhibitor |
| gptkbp:CASNumber |
gptkb:152121-30-7
|
| gptkbp:hasMolecularFormula |
gptkb:C21H16FN3O
|
| gptkbp:hasSMILES |
CS(=O)c1ccc(cc1)c2nc(nc2c3ccc(F)cc3)c4ccncc4
|
| https://www.w3.org/2000/01/rdf-schema#label |
SB203580
|
| gptkbp:inhibitedBy |
gptkb:p38_MAP_kinase
|
| gptkbp:is_not_approved_for_clinical_use |
true
|
| gptkbp:IUPACName |
gptkb:4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine
|
| gptkbp:mechanismOfAction |
ATP-competitive inhibitor
|
| gptkbp:molecularWeight |
337.38 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL29997
5353947 |
| gptkbp:target |
gptkb:MAPK11
gptkb:MAPK14 |
| gptkbp:used_in |
biochemical research
|
| gptkbp:bfsParent |
gptkb:MAPK_signaling_pathway
gptkb:p38_MAPK_pathway |
| gptkbp:bfsLayer |
6
|